Literature DB >> 16806508

Inducible proteopathies.

Lary C Walker1, Harry Levine, Mark P Mattson, Mathias Jucker.   

Abstract

Numerous degenerative diseases are characterized by the aberrant polymerization and accumulation of specific proteins. These proteopathies include neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and the prion diseases, in addition to diverse systemic disorders, particularly the amyloidoses. The prion diseases have been shown to be transmissible by an alternative conformation of the normal cellular prion protein. Other proteopathies have been thought to be non-transmissible, but there is growing evidence that some systemic and cerebral amyloidoses can be induced by exposure of susceptible hosts to cognate molecular templates. As we review here, the mechanistic similarities among these diseases provide unprecedented opportunities for elucidating the induction of protein misfolding and assembly in vivo, and for developing an integrated therapeutic approach to degenerative proteopathies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806508     DOI: 10.1016/j.tins.2006.06.010

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  39 in total

1.  Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.

Authors:  Amanda M Gleixner; Jessica M Posimo; Deepti B Pant; Matthew P Henderson; Rehana K Leak
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

2.  Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats.

Authors:  Rebecca F Rosen; Jason J Fritz; Jeromy Dooyema; Amarallys F Cintron; Tsuyoshi Hamaguchi; James J Lah; Harry LeVine; Mathias Jucker; Lary C Walker
Journal:  J Neurochem       Date:  2011-11-18       Impact factor: 5.372

3.  Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6.

Authors:  Birgit S Berger; Sergio P Acebron; Jessica Herbst; Stefan Koch; Christof Niehrs
Journal:  EMBO Rep       Date:  2017-03-24       Impact factor: 8.807

4.  Predicting regional neurodegeneration from the healthy brain functional connectome.

Authors:  Juan Zhou; Efstathios D Gennatas; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

Review 5.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 6.  Exfoliation Syndrome: A Disease of Autophagy and LOXL1 Proteopathy.

Authors:  Audrey M Bernstein; Robert Ritch; Jose M Wolosin
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

Review 7.  The expanding realm of prion phenomena in neurodegenerative disease.

Authors:  Bess Frost; Marc I Diamond
Journal:  Prion       Date:  2009-04-16       Impact factor: 3.931

8.  Mouse senile amyloid fibrils deposited in skeletal muscle exhibit amyloidosis-enhancing activity.

Authors:  Jinze Qian; Jingmin Yan; Fengxia Ge; Beiru Zhang; Xiaoying Fu; Hiroshi Tomozawa; Jinko Sawashita; Masayuki Mori; Keiichi Higuchi
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

10.  Distinct type of transmission barrier revealed by study of multiple prion determinants of Rnq1.

Authors:  Michele L Kadnar; Gulnara Articov; Irina L Derkatch
Journal:  PLoS Genet       Date:  2010-01-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.